List Labs will be closed for the holidays from December 23rd to January 1st. We look forward to responding to your inquiry as soon as we return.

Years of Know-
How
Advancing
Bacterial Therapeutics

Years of Know-
How Advancing
Bacterial Therapeutics

Services

Our Services

List Labs is one of the most experienced CDMOs for bacterially-based products, with years of expertise supporting clients, including innovators developing LBPs and bacterial derived products for the microbiome therapeutics and biopharmaceutical markets.

We offer a full range of
CDMO services from early-stage

We offer a full range of services from early-stage process development to cGMP manufacturing for Phase I & II clinical supply, meeting the needs of pharmaceutical companies, biotechs, start-ups, and government organizations. Our expertise includes development and manufacturing of bacterial derived products from purified polysaccharides and proteins to live bacteria.

We are also currently planning our expansion to add Phase III and commercial manufacturing at a new facility, which will enhance our fully integrated CDMO offering.

Great stories
from great customers

“We are pleased to be partnering with List Labs in the manufacturing of our proprietary interferon alpha 2b. We believe our novel engineered interferon alpha 2b derived from our proprietary master cell bank offers important advantages that allows for a quick scale up of manufacturing, especially in terms of logistics and cost of goods,..

Dr. Doroudian, Altum Pharma

“List labs staff are scientifically sound and very responsive to needs during difficult times, especially during GMP manufacturing.”

Microbiome Therapeutic Company in Phase I Clinical Trials

“Microbiome-based drugs, designated live biotherapeutic products by FDA, are quite different from other biologics because the bacterium itself is the drug. Few CDMOs in the US have the expertise to manufacture LBPs, so we were fortunate to find List Biological Laboratories in Campbell, CA to produce our LBP for Phase 2 clinical trials. List Labs successfully produced both drug substance and a complex drug product under one roof, which saved us considerable time and money. We would recommend List Labs to companies with innovative products who are looking for a manufacturer of early stage clinical products.”

Microbiome Therapeutic Company in Phase II Clinical Trials

“List Labs has consistently provided us with the highest level of service and quality for development and cGMP manufacturing of our live biotherapeutic product for Phase I clinical trials, while remaining sensitive to our cost requirements and timelines.  I would strongly recommend them for any future project.”

Scioto Biosciences

“We have been using your PT and FHA antigens for decades, and LOVE them!”

Harry Prince, Scientific Director for Immunology, Focus Diagnostics

“We are pleased to be partnering with List Labs in the manufacturing of our proprietary interferon alpha 2b. We believe our novel engineered interferon alpha 2b derived from our proprietary master cell bank offers important advantages that allows for a quick scale up of manufacturing, especially in terms of logistics and cost of goods,..

Dr. Doroudian, Altum Pharma

“List labs staff are scientifically sound and very responsive to needs during difficult times, especially during GMP manufacturing.”

Microbiome Therapeutic Company in Phase I Clinical Trials

“Microbiome-based drugs, designated live biotherapeutic products by FDA, are quite different from other biologics because the bacterium itself is the drug. Few CDMOs in the US have the expertise to manufacture LBPs, so we were fortunate to find List Biological Laboratories in Campbell, CA to produce our LBP for Phase 2 clinical trials. List Labs successfully produced both drug substance and a complex drug product under one roof, which saved us considerable time and money. We would recommend List Labs to companies with innovative products who are looking for a manufacturer of early stage clinical products.”

Microbiome Therapeutic Company in Phase II Clinical Trials

“List Labs has consistently provided us with the highest level of service and quality for development and cGMP manufacturing of our live biotherapeutic product for Phase I clinical trials, while remaining sensitive to our cost requirements and timelines.  I would strongly recommend them for any future project.”

Scioto Biosciences

“We have been using your PT and FHA antigens for decades, and LOVE them!”

Harry Prince, Scientific Director for Immunology, Focus Diagnostics